MOBI Earnings Date: Nov 5, 2026 (Estimated) — Mobia Medical, Inc. Common Stock

NASDAQ

Updated Oct 30, 2026

Price $10.96

Market Cap $375.2M

P/E -6.3

52W Range $8.03 – $15.29

Next Earnings Nov 5, 2026 · After close (est.)

When is MOBI's next earnings date?

Mobia Medical, Inc. Common Stock (MOBI) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 6:17 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.46 on revenue of $14.0M.

How did MOBI do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Mobia Medical, Inc. Common Stock posted EPS of -$1.10 versus the -$0.71 estimate, a miss of 34.2%. Revenue was $13.5M against a $12.2M estimate. The stock's 1-day post-earnings move was -8.4%.

How much does MOBI stock move after earnings?

MOBI beat EPS estimates in 0 of its last 1 reported quarter. Over the last 2 reports the stock moved an average of 8.6% (up or down) in the day after earnings.

About Mobia Medical, Inc. Common Stock

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.